Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study

Eur J Clin Microbiol Infect Dis. 2022 Nov;41(11):1365-1370. doi: 10.1007/s10096-022-04500-w. Epub 2022 Sep 30.

Abstract

In order to characterize pneumococcal endovascular infection in the post-vaccination era, a retrospective nationwide study based on the Israeli Adult IPD database was conducted. Between 2010 and 2019, 0.6% (23 cases) of IPD cases were of endovascular type, occurring mainly in males (72.3%) with underlying medical conditions (78.2%). Additional pneumococcal source (10 patients) and concomitant infections were not uncommon. Penicillin and ceftriaxone susceptibility rates were 65.2% and 91.3%, respectively; 60.9% of the isolates were not covered by the pneumococcal conjugate vaccine. 21.7% of patients died during hospitalization. In conclusion, pneumococcal endovascular infections still carry significant morbidity and mortality.

Keywords: Endovascular infections; Infective endocarditis; Invasive pneumococcal disease; Streptococcus pneumoniae.

MeSH terms

  • Adult
  • Ceftriaxone*
  • Humans
  • Infant
  • Male
  • Penicillins
  • Pneumococcal Infections* / epidemiology
  • Pneumococcal Infections* / microbiology
  • Pneumococcal Infections* / prevention & control
  • Pneumococcal Vaccines
  • Retrospective Studies
  • Serotyping
  • Vaccines, Conjugate

Substances

  • Penicillins
  • Pneumococcal Vaccines
  • Vaccines, Conjugate
  • Ceftriaxone

Grants and funding